• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Latest Advances in CGM Technology: A 5-question Quiz

Article

Continous glucose monitors (CGMs) received a flurry of US Food and Drug Administration (FDA) appprovals in 2018. Since then, the FDA-approved CGMs have benefited from a variety of enhanced features, new applications, and new approvals that promise to further advance the management of diabetes and thus the functioning and quality of life of patients with diabetes.

Take the 5-question quiz below to see what you know about key original CGM approvals and features and the innovations and advances that have been approved since.


1. Which of the following was the first FDA-approved CGM system to include a fully implantable sensor to detect glucose?


Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
© 2024 MJH Life Sciences

All rights reserved.